ARG1 and idiopathic pulmonary fibrosis: Regarding the urea cycle, pirfenidone, an ARG1 inhibitor, has shown positive results in patients with idiopathic pulmonary fibrosis, and therefore inhibition of ARG1 might be a valuable therapeutic aim in SSc [66].